Stock SCOL SCANDION ONCOLOGY A/S
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Scandion Oncology A/S

Equities

SCOL

DK0061031895

Market Closed - Nasdaq Stockholm
Other stock markets
 09:30:00 28/06/2024 pm IST 		5-day change 1st Jan Change
0.29 SEK -5.23% Intraday chart for Scandion Oncology A/S -26.02% -92.74%
22/05 Transcript : Scandion Oncology A/S, Q1 2024 Earnings Call, May 22, 2024
22/05 Scandion Oncology A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Scandion Oncology A/S Appoints Lars Damstrup, MD, PhD, as Chief Medical Officer
CI
Scandion Oncology Appoints Co-Founder as Chief Scientific Officer
MT
Scandion Oncology Appoints Jan Stenvang, Ph.D., Chief Scientific Officer and Member of Executive Management
CI
Scandion Oncology Appoints Francois Martelet as New Chief Executive Officer, Effective from January 2, 2023
CI
Scandion Oncology President/CEO Steps Down, CFO Named Interim CEO
MT
Scandion Oncology A/S Announces Board and Executive Changes
CI
Scandion Oncology A/S Announces CEO Changes
CI
Scandion Oncology's COO to Step Down in December
MT
Scandion Oncology Announces Change to Its Executive Management
CI
Scandion Oncology Announces Resignation of Thomas Feldthus from the Board of Directors
CI
Scandion Oncology Names New Chief Medical Officer
MT
Scandion Oncology A/S Announces Chief Medical Officer Change
CI
Scandion Oncology A/S Appoints Mads Kronborg as Head of External Communication
CI
Scandion Oncology A/S Announces Clinical Advisory Board Changes
CI
Scandion Oncology A/S Elects Martin Møller to Board of Directors
CI
Scandion Oncology Appoints Richard L. Schilsky to Its Clinical Advisory Board
CI
Scandion Oncology A/S Appoints Maj Hedtjärn as New COO and Head of R&D Operations
CI
CSO Nils Brünner to Retire from Scandion Oncology A/S
CI
Scandion Oncology Appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations
CI
Scandion Oncology Appoints Bo Rode Hansen as CEO, Effective October 1, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SCOL Stock
  4. News Scandion Oncology A/S
  5. Insiders